Stella Chemifa Corporation
Stock Price Chart
2026/10/09 12:26 UpdatedPrice Trend
2026/10/09 12:26 UpdatedPrice & Trading Details
2026/10/09 12:26 UpdatedPRICE
TRADING
Analyst Recommendations 1 analysts
Updated 2026/10/01Shareholder Composition
Updated 2026/10/01Top Mutual Funds / ETFs
Updated 2026/10/01Major Holders
Updated 2026/10/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
121.5K | 0.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
89.5K | 0.00% | |
|
WisdomTree Trust-WisdomTree Japan Hedged Equity Fund
|
58.6K | -1.51% | |
|
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
|
46.9K | 0.00% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.
|
42.3K | 0.00% | |
|
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Small-Cap
|
35.0K | +9.03% |
Dividend History 1Years Growth
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥185 | +8.8% |
| 2025 | ¥170 | -5.0% |
| 2024 | ¥179 | +98.9% |
| 2023 | ¥90 | +36.4% |
| 2022 | ¥66 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥35,382M | ¥30,446M | ¥36,288M | ¥36,799M |
| Gross Profit | ¥7,410M | ¥6,446M | ¥8,257M | ¥8,581M |
| Operating Income | ¥3,514M | ¥2,722M | ¥4,339M | ¥4,645M |
| Pretax Income | ¥3,398M | ¥2,643M | ¥4,263M | ¥4,469M |
| Net Income | ¥2,280M | ¥1,845M | ¥2,892M | ¥3,058M |
| EPS | ¥186.03 | ¥153.48 | ¥241.00 | ¥258.45 |
| Operating Margin | 9.93% | 8.94% | 11.96% | 12.62% |
| Balance Sheet | ||||
| Total Assets | ¥55,471M | ¥58,618M | ¥60,725M | ¥64,149M |
| Total Equity | ¥42,922M | ¥44,260M | ¥44,751M | ¥47,823M |
| Total Liabilities | ¥12,549M | ¥14,358M | ¥15,974M | ¥16,326M |
| Cash | ¥15,097M | ¥16,225M | ¥16,643M | ¥14,817M |
| Interest-bearing Debt | ¥3,922M | ¥4,927M | ¥5,373M | ¥5,555M |
| Equity Ratio | 77.38% | 75.51% | 73.69% | 74.55% |
| D/E Ratio | 0.09 | 0.11 | 0.12 | 0.12 |
| Cash Flow | ||||
| Operating CF | ¥5,634M | ¥6,542M | ¥7,115M | ¥6,009M |
| Investing CF | -¥3,281M | -¥5,831M | -¥4,324M | -¥8,162M |
| Financing CF | -¥3,717M | -¥141M | -¥2,828M | ¥151M |
| Free CF | ¥1,046M | ¥683M | ¥2,945M | ¥1,421M |
| Efficiency | ||||
| ROE | 5.31% | 4.17% | 6.46% | 6.39% |
| ROA | 4.11% | 3.15% | 4.76% | 4.77% |
Latest IR Information
-
Notice on Status of Treasury Stock Acquisition (Acquisition of Treasury Stock Based on the Provisions of Article 459, Paragraph 1 of the Companies Act)
The shares acquired were common shares totaling 145,100 shares, with a total purchase price of 768,920,000 yen. The acquisition period was September 1, 2026 to September 30, 2026 (on a trade basis), and the method was market purchase. At the...
Read more -
Notice Regarding Share Buyback Status
Discloses the status of treasury stock acquisition. Acquired 111,800 shares for a total of 6,040,455,00 yen, during the period from August 7, 2026 to August 31, 2026 (execution basis), via market purchases. Based on the August 6 board resolution, the...
Read more -
Responses toward realizing management mindful of capital cost and stock price (Update)
Under the premise of growth investment in semiconductor-related areas, optimize capital structure and aim for a total return orientation of over 100%. Currently focusing on improving capital efficiency and strengthening balance sheet management with a target equity ratio of 50–60%....
Read more -
Notice Regarding the Determination of Matters Related to Treasury Stock Acquisition
Decided to acquire treasury stock. The total amount cap is 1,900,000,000 yen (upper limit); the number of shares to be acquired is unspecified. Acquisition period is from August 7, 2026 to October 30, 2026. Aims to strengthen shareholder returns and...
Read more -
Stellar Chemifa: Q1 FY2027 Financial Summary (Japanese GAAP, Consolidated) — Sales 9,754 million yen, Net income 1,094 million yen
Net sales of 9,754 million yen (YoY +10.9%), operating income of 1,242 million yen ( +1.6%), ordinary income of 1,176 million yen (+2.4%), net income attributable to owners of the parent 1,094 million yen (+32.1%), with profit growth. The planned...
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥6,250
Rating Score: 1.00 (Based on 1 analysts)
※1=Strong Buy, 5=Strong Sell
Stella Chemifa Advances Share Buyback, Repurchases Over 85% of Authorized Shares - TipRanks ↗
Company Information
About
Stella Chemifa Corporation manufactures and sells high-purity chemical products in Japan and internationally. It offers hydrofluoric acid, ammonium fluoride, buffered hydrofluoric acid, HG series, and etching solutions used in semiconductors and liquid crystal products; calcium, aluminum, lithium, strontium, barium, magnesium, lead fluoride and fluoride nanoparticles used in optical materials; and lithium hexafluorophosphate and fluoride nanoparticles for batteries. The company also provides boron trifluoride, boron trifluoride diethyl ether, boron trifluoride dimethyl ether, boron trifluoride n-butyl ether, boron trifluoride tetrahydrofuran, boron trifluoride phenol, boron trifluoride monoethyl amine, boron trifluoride piperidine, and triethylamine 3HF used in reactive catalysts; and hydrofluoric acid, ammonium fluoride, ammonium hydrogenfluoride, and borofluoride used in surface treatment and alternatives for CFCs. In addition, it offers potassium fluoroborate and boric acid for nuclear energy applications; tin fluoride (II) USP used in GMP-compliant products; and other products, such as potassium fluoride, calcium fluoride, potassium hexafluorozirconate, potassium hexafluorotitanate, sodium fluoride, potassium fluorosilicate, sodium hexafluorosilicate, magnesium hexafluorosilicate, fluoroboric acid, zinc fluoroborate, potassium fluorosilicate, tin fluoroborate, copper fluoroborate, sodium fluoroborate, lead fluoroborate, ammonium hydrogenfluoride, and potassium hexafluorophosphate. Further, the company transportation business, including shipping, custom brokerage, warehousing, and container services. Additionally, it develops Boron Neutron Capture therapy for the treatment of cancer. The company was formerly known as Hashimoto Chemical Corporation and changed its name to Stella Chemifa Corporation in 1997. Stella Chemifa Corporation was founded in 1916 and is headquartered in Osaka, Japan.